Skip to main content
HEALIUS LIMITED logo

HEALIUS LIMITED — Investor Relations & Filings

Ticker · HLS ISIN · AU0000033359 LEI · 529900MBZK3SLWK8SJ55 ASX Human health and social work activities
Open in API
Filings indexed 2,292 across all filing types
Latest filing 2024-06-24 Capital/Financing Update
Country AU Australia
Listing ASX HLS

About HEALIUS LIMITED

https://www.healius.com.au

Healius Limited is a leading healthcare service provider specializing in pathology and diagnostic imaging services. The company operates an extensive network of pathology laboratories and collection centers, providing diagnostic testing across various medical disciplines including biochemistry, hematology, and microbiology. Its diagnostic imaging division offers a comprehensive range of services such as X-rays, ultrasounds, CT scans, and MRIs through a network of community-based and hospital-integrated clinics. Healius focuses on delivering high-quality diagnostic insights to healthcare professionals and patients, leveraging advanced technology and a large-scale infrastructure to support clinical decision-making and patient care outcomes.

Recent filings

Filing Released Lang Actions
Healius announces Trading Update for FY 2024 1 page
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement titled 'Healius announces Trading Update for FY 2024'. It provides forward-looking financial metrics such as expected EBITDA and EBIT for the fiscal year 2024, commentary on business performance, and operational updates. The document is short (1799 characters) and focuses on a trading update rather than detailed financial statements or comprehensive analysis. It does not contain full financial statements or detailed management discussion typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a simple announcement of a report publication. Therefore, the document fits best into the category of Capital/Financing Update (CAP), which includes updates on company financial performance and outlooks that are not full earnings releases or reports.
2024-06-24 English
Change in substantial holding 4 pages 1.4MB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, specifically a "Notice of change of interests of substantial holder." It details changes in voting power and relevant interests of a substantial shareholder in Healius Limited, including dates, share quantities, and transactions. The form is regulatory in nature, reporting changes in major shareholdings rather than financial results, management changes, or other report types. This matches the definition of a Major Shareholding Notification (MRQ). The document length is sufficient and contains detailed transaction data, confirming it is not a mere announcement or certification but the actual notification. Therefore, the correct classification is MRQ with high confidence.
2024-06-23 English
Healius announces Group Executive of Pathology departure 1
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 14 June 2024 regarding the departure of a Group Executive of Pathology at Healius Limited. It discusses management changes, specifically the resignation of a senior executive and interim leadership arrangements. There is no financial data, no report attached or referenced, and the content focuses solely on management personnel changes. According to the filing definitions, announcements about changes in senior management fall under Board/Management Information (MANG). The document length is short (2269 characters), and it is clearly an announcement rather than a report or presentation.
2024-06-13 English
Change in substantial holding 23 pages 962.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001, Section 671B, which is a Notice of change of interests of a substantial holder. It details changes in voting power, relevant interests, and associations related to substantial shareholdings in Healius Ltd by JPMorgan Chase & Co. and its affiliates. The document includes specific shareholding changes, transaction details, and signatures. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2024-06-05 English
Change in substantial holding from PPT 7 pages 607.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder (Perpetual Limited) in Healius Limited. The form includes dates of changes, previous and present voting power percentages, and transaction details in annexures. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is lengthy (15,000 characters) and contains detailed transaction data, not just an announcement or certification, confirming it is the actual notification filing.
2024-06-05 English
Update on Strategic Review and Chair Appointment 2 pages 223.5KB
Board/Management Information Classification · 95% confidence The document is an ASX announcement from Healius Limited dated 27 May 2024. It provides an update on the completion of an operating and strategic review, including the initiation of a formal process to explore the sale of a division (Lumus Imaging). It also announces the appointment of a new Chair of the Board, Kate McKenzie. The content focuses on strategic business updates and board management changes rather than detailed financial results or comprehensive reports. The document length is 3590 characters, which is relatively short and typical for an announcement rather than a full report. There is no detailed financial data or comprehensive analysis that would classify it as an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). The key elements are the strategic review update and the appointment of a new Chair, which fits best under Board/Management Information (MANG).
2024-05-26 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.